New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
November 4, 2024 - Journey Medical announced the FDA approval of Emrosi (minocycline), to treat inflammatory lesions (papules and pustules) of rosacea in adults.
Download PDF
Return to publications
